-
公开(公告)号:CA2679985A1
公开(公告)日:2008-09-18
申请号:CA2679985
申请日:2008-03-05
Applicant: HOFFMANN LA ROCHE
Inventor: ROGERS-EVANS MARK , KNUST HENNER , NETTEKOVEN MATTHIAS , ROCHE OLIVIER , MALHERBE PARICHEHR , PINARD EMMANUEL , GOBBI LUCA
IPC: C07C233/08 , A61K31/167 , C07C233/15 , C07C233/22
Abstract: The present invention relates to compounds of formula wherein Ar1 and Ar2 are independently from each other unsubstituted or substituted aryl or hete roaryl; R1/R2 are independently from each other hydrogen, lower alkyl, lower alkyl substituted by halogen, -(CH2)o-O-lower alkyl, -(CH2)o-N-(lower alkyl )2, (CH2 )p-cycloalkyl, (CH2)p-heterocycloalkyl, (CH2)p-aryl, (CH2)p-heteroa ryl, which rings may be substituted by R, or R1 and R2 may form together wit h the N-atom to which they are attached a heterocyclic ring, optionally with further ring-heteroatoms selected from N, O or S, which ring may be substit uted by R; R is halogen, lower alkyl, lower alkyl substituted by halogen, lo wer alkoxy or lower alkoxy substituted by halogen; R3 is hydrogen or lower a lkyl; n is O, 1, 2, 3 or 4; o is 1, 2 or 3; P is 0, 1 or 2; or to pharmaceut ically suitable acid addition salts, optically pure enantiomers, racemates o r diastereomeric mixtures thereof. It has been found that the compounds of f ormula I are orexin receptor antagonists and the related compounds may be us eful in the treatment of disorders, in which orexin pathways are involved li ke sleep disorders.
-
公开(公告)号:AU2008225922A1
公开(公告)日:2008-09-18
申请号:AU2008225922
申请日:2008-03-05
Applicant: HOFFMANN LA ROCHE
Inventor: PINARD EMMANUEL , ROGERS-EVANS MARK , ROCHE OLIVIER , MALHERBE PARICHEHR , GOBBI LUCA , KNUST HENNER , NETTEKOVEN MATTHIAS
IPC: C07C233/08 , A61K31/167 , C07C233/15 , C07C233/22
Abstract: The present invention relates to compounds of formula I wherein Ar1, Ar2, R, R1, R2, R3 and n are as defined herein or to pharmaceutically suitable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. Compounds of formula I are orexin receptor antagonists and may be useful in the treatment of disorders, in which orexin pathways are involved like sleep disorders.
-
73.
公开(公告)号:MX373153B
公开(公告)日:2025-03-04
申请号:MX2016002234
申请日:2016-02-19
Applicant: HOFFMANN LA ROCHE
Inventor: MURI DIETER , KNUST HENNER , GOBBI LUCA , KOERNER MATTHIAS
IPC: C07D471/04 , A61K31/44 , A61P25/28
Abstract: La presente invención se refiere a un compuesto de fórmula general (Ver Fórmula) la que R es hidrógeno o tritio; F es Flúor o 18flúor; o a una sal de adición de ácido farmacéuticamente aceptable. Los compuestos de fórmula I incluyen 2-(6-fluoro-piridin-3-il)-9H-dipirido [2,3-b;3',4'-d]pirrol,3H-2-(6-fluoro-piridin3-il)-9H-dipirido[2,3-b;3',4'-d]pirrol y [18F]-2-(6-fluoro-piridin-3-il)-9H-dipirido[2,3-b;3',4'-d]pirrol. Los compuestos se pueden usar para la unión y la formación de imágenes de agregados de tau y los agregados de lámina beta relacionados incluyendo entre otros agregados de beta-amiloide o agregados de alfa-sinucleína.
-
公开(公告)号:HRP20241201T1
公开(公告)日:2024-11-22
申请号:HRP20241201
申请日:2019-08-12
Applicant: HOFFMANN LA ROCHE
Inventor: BELL CHARLES , BENZ JOERG , GOBBI LUCA , GRETHER UWE , GROEBKE ZBINDEN KATRIN , HORNSPERGER BENOIT , KOCER BUELENT , KROLL CARSTEN , KUHN BERND , LUTZ MARIUS DANIEL RINALDO , O'HARA FIONN , RICHTER HANS , RITTER MARTIN , ROMBACH DIDIER , KURATLI MARTIN
IPC: C07D498/04 , A61K31/5365 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/24 , A61P25/28 , A61P35/00
-
公开(公告)号:AU2019294256B2
公开(公告)日:2024-06-20
申请号:AU2019294256
申请日:2019-06-25
Applicant: ETH ZUERICH , F HOFFMANN LA ROCHE AG
Inventor: GOBBI LUCA , GRETHER UWE , KRETZ JULIAN , AMETAMEY SIMON M
IPC: C07D401/04 , A61K31/4427 , A61K31/4439 , A61P7/02 , A61P9/00 , A61P23/02 , A61P27/06 , A61P29/00
Abstract: The invention relates to a compound of formula (I) wherein A, A
-
76.
公开(公告)号:CA3232152A1
公开(公告)日:2023-04-13
申请号:CA3232152
申请日:2022-10-04
Applicant: HOFFMANN LA ROCHE
Inventor: BARTELS BJOERN , CECERE GIUSEPPE , GOBBI LUCA , HERNANDEZ MARIA-CLEMENCIA , HUMM ROLAND , OLIVARES MORALES ANDRES MIGUEL , PATINY-ADAM ANGELIQUE , RUNTZ-SCHMITT VALERIE , SCHNIDER CHRISTIAN
IPC: C07D243/24 , A61K31/5513 , A61K31/5517 , A61P25/00 , C07D243/26 , C07D487/04
Abstract: The invention provides novel heterocyclic compounds having the general formula (I) or (II), and pharmaceutically acceptable salts thereof, wherein the variables are as described herein. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds for the treatment or prevention of acute neurological disorders, chronic neurological disorders and/or cognitive disorders.
-
公开(公告)号:BR112022005472A2
公开(公告)日:2022-06-14
申请号:BR112022005472
申请日:2020-09-22
Applicant: HOFFMANN LA ROCHE
Inventor: HORNSPERGER BENOIT , KUHN BERND , KROLL CARSTEN , O'HARA FIONN , RICHTER HANS , KATRIN GROEBKE ZBINDEN , GOBBI LUCA , MARIUS DANIEL RINALDO LUTZ , RITTER MARTIN , GRETHER UWE
IPC: C07D491/04 , A61K31/5375 , A61P25/00 , A61P35/00 , A61P37/00
Abstract: nibidores heterocíclicos de monoacilglicerol lipase (magl), seus usos, processo de fabricação e composição farmacêutica. a presente invenção refere-se a compostos heterocíclicos que são inibidores de monoacilclicerol lipase (magl) tendo a fórmula geral (i) em que a, l1, x, m, n e r1 a r4 são como descritos no presente documento, composições incluindo os compostos, processos de fabricação dos compostos e métodos de uso dos compostos.
-
公开(公告)号:MY190196A
公开(公告)日:2022-04-04
申请号:MYPI2016000604
申请日:2014-10-06
Applicant: HOFFMANN LA ROCHE
Inventor: GOBBI LUCA , KNUST HENNER , KOERNER MATTHIAS , MURI DIETER
IPC: C07D471/04 , A61K31/44 , A61P25/28
Abstract: The present invention relates to a compound of general formula wherein R is hydrogen or tritium; F is fluoro or 18fluoro; or to a pharmaceutically acceptable acid addition salt. Compounds cif formula I include 2-(6-fluoro-pyridin-3-yl)-9H-dipyrido[2,3-b;3 ',4'-d]pyrrole, H-2-(6-fluoro-pyridin-3-yl)-9H-dipyrido[2,3-b;3',4'-d]pyrrole and [ 18F]-2-( 6-fluoro-pyridin-3-yl)-9H-dipyrido[2,3-b;3 ',4'-d]pyrrole. The compounds may be used for binding and imaging tau aggregates and related beta-sheet aggregates including besides others beta-amyloid aggregates or alpha-synuclein aggregates. (No suitable figure)
-
公开(公告)号:CO2022001879A2
公开(公告)日:2022-03-29
申请号:CO2022001879
申请日:2022-02-22
Applicant: HOFFMANN LA ROCHE
Inventor: GOBBI LUCA , BENZ JOERG , GRETHER UWE , RICHTER HANS , GROEBKE ZBINDEN KATRIN , HORNSPERGER BENOIT , KROLL CARSTEN , KUHN BERND , O`HARA FIONN , RITTER MARTIN , MARTIN RAINER E , PUELLMANN BERND
IPC: C07D498/04 , A61K31/5383 , A61P25/28 , A61P29/00 , A61P35/00
Abstract: La invención proporciona nuevos compuestos heterocíclicos que tienen la Fórmula general (I) en donde A, B, L1, X, m, n, y R1 a R7 son como se describen en la presente, composiciones que incluyen los compuestos, procesos de elaboración de los compuestos y métodos de uso de los compuestos como inhibidores de monoacilglicerol lipasa (MAGL).
-
公开(公告)号:AU2020356241A1
公开(公告)日:2022-02-17
申请号:AU2020356241
申请日:2020-09-22
Applicant: F HOFFMANN LA ROCHE AG
Inventor: BENZ JOERG , GOBBI LUCA , GRETHER UWE , HORNSPERGER BENOIT , KROLL CARSTEN , KUHN BERND , MARTIN RAINER E , O'HARA FIONN , PUELLMANN BERND , RICHTER HANS , RITTER MARTIN
IPC: C07D498/04 , A61P25/06 , A61P25/08 , A61P25/14 , A61P25/22 , A61P25/24 , A61P25/28 , A61P29/00 , A61P35/00 , A61P37/00
Abstract: The invention provides new heterocyclic compounds having the general formulae (Ia) and (Ib) (Formula Ia, Ib) wherein A, B, and L are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
-
-
-
-
-
-
-
-
-